Results 201 to 210 of about 242,137 (307)

Clinical and Radiographic Performance of Two Distinct Sandblasted, Large‐Grit, Acid‐Etched Implant Surfaces: A Split‐Mouth Randomized Clinical Trial

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Aim To compare the clinical performance of two sandblasted, large‐grit, acid‐etched implant surfaces regarding changes in radiographic marginal bone level (MBL) 12 months after loading. Materials and Methods In this randomized, split‐mouth, dual‐center clinical trial, each patient received one test (modified hydrophilic surface) implant and ...
Blanca Vílchez   +7 more
wiley   +1 more source

Rescue Therapy With Quad Zygoma After Failure of Full‐Arch Implant Rehabilitation: A Retrospective Study With a Mean Follow‐Up of 8 Years

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To evaluate the long‐term clinical outcomes of quad zygomatic implants (ZIs) as a rescue therapy for patients with failed full‐arch implant rehabilitation in the maxilla due to advanced peri‐implantitis. Material and Methods This was a retrospective cohort study of all patients treated with the Quad Zygoma Protocol. Primary outcomes
Shengchi Fan   +4 more
wiley   +1 more source

Comparison of Piezoelectric and High‐Speed Drills for Frontal Beak Osteotomy in Endoscopic Sinus Surgery—Exploratory Study

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Introduction Frontal beak reduction is a critical and challenging step in endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS). Traditional high‐speed drills can risk thermal injury and soft tissue trauma, whereas piezoelectric surgery uses ultrasonic vibrations for selective bone cutting and may improve surgical precision.
Łukasz Skrzypiec   +4 more
wiley   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina   +5 more
wiley   +1 more source

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care

open access: yes
Clinical &Experimental Allergy, EarlyView.
R. Soegiharto   +6 more
wiley   +1 more source

An oral glucose tolerance test in pregnancy and its association with future cardiovascular diseases

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims/hypothesis Gestational diabetes and abnormal 100‐g oral glucose tolerance test (OGTT) results in pregnancy are associated with type 2 diabetes, but their relationship with cardiovascular disease (CVD) is less clear. We evaluated the risk of CVD according to the number of abnormal OGTT values during pregnancy.
Tal Schiller   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy